All News

Exposure to secondhand smoke, coupled with genetic traits, increases the risk of bladder cancer for nonsmokers, reported researchers from the University of Minnesota Masonic Cancer Center, Minneapolis.

A blood test for certain forms of PSA and measurement of DNA content in biopsy tissue accurately predict which men with potentially non-lethal prostate cancers may eventually need treatment, say urologists from Johns Hopkins University, Baltimore.

Gonadotropin-releasing hormone (GnRH) agonists have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several FDA studies.

Urology drugs and devices that are in the pipeline.

Urologists should be aware of the links between hypogonadism and other serious health issues, as androgen deficiency may be the first clinically apparent sign of additional, future medical problems.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II bladder cancer trials that are currently recruiting participants. This list is current as of April 7, 2010.

The two biggest issues that come to mind in light of the current economic climate are how well you're communicating within the urology practice and how the economy might affect staff performance.

San Francisco has cuisine to satisfy any taste buds. From dim sum to gnocchi, use this guide to map out your dining tour of the city by the bay. Note: All phone numbers use the area code 415.

The more knowledge we have, the better informed decisions we'll be able to promote and help our patients make.

A trial currently under way may help urologists to separate responders from nonresponders early and tailor BCG therapy for optimal results in those bladder cancer patients who respond to the drug.

It may be time to put surgical-style checklists to use in the office. This article, which details one of the author's own experience, explains why.

San Francisco's diverse and unique offerings-neighborhoods, attractions, arts, culture, and nightlife-are unparalleled in the United States.

As part of reform, It is clear that the government is starting to tighten control of physician-owned ancillary services.

Urologists and their patients may soon be able to determine renal cell tumor histology without surgery or biopsy.

Injections of autologous muscle-derived cells appear to be both safe and effective in the treatment of stress urinary incontinence, with a trend toward greater effectiveness at higher doses.

Overall, most of the urologists who were interviewed considered the CT scan the gold standard for approaching many diagnoses.

What is it going to take for Congress to stop playing games with physicians who treat Medicare patients and develop an effective solution to the fee cuts that are scheduled every year and require last-minute, short-term solutions?

Significant time is spent developing methods or strategies that come close to that "perfect investment." None is as popular or compelling as Modern Portfolio Theory.

Although the request to revise the urodynamics codes was initiated by Medicare, the request was to change the CPT code descriptions to reflect the fact that the old 51772 and the old 51795 were billed in conjunction with code 51726 almost all the time.

Radical prostatectomy has changed dramatically over the past 20 years. A procedure that once carried a significant degree of perioperative morbidity, particularly in high-risk patients, has become relatively routine in high-volume centers.

Selenium and vitamin are E not promising, but both the Prostate Cancer Prevention Trial and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial showed a 20% to 25% reduction in the incidence of prostate cancer from two different 5-alpha-reductase inhibitors, finasteride (Proscar) and dutasteride (Avodart).

The development of targeted molecular therapies offers new avenues for combining pharmacologic and surgical therapies in the treatment of advanced renal cell carcinoma.

Receiving a diagnosis of prostate cancer is accompanied by significantly increased risks of suicide and cardiovascular death, according to recent results of a U.S. population-based cohort study.

The first-ever presentation of phase III data from the investigational taxane cabazitaxel showed a 30% improvement in survival in men with metastatic castration-resistant prostate cancer.

Researchers for the Urinary Incontinence Treatment Network found that the minimum important difference for the Urogenital Distress Inventory was –35 to –45 points in patients with urge urinary incontinence.

Enough evidence has linked ADT to cardiovascular events and diabetes to warrant a recent science advisory compiled by AUA, the American Heart Association, American Cancer Society, and American Society for Radiation Oncology.

Evidence that percutaneous tibial nerve stimulation is an effective, drug-free treatment for overactive bladder is mounting. A double-blind, sham-controlled, multicenter trial showed a response rate of about 50% in patients who have struggled with symptoms for a decade.

The following pages feature products and services from manufacturers that are exhibiting at the American Urological Association annual meeting in San Francisco. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.